Quarter earnings

Wegovy, Novo Nordisk, Quarter earnings, Drug shortage, Billion-Dollar, Weight Loss Drug

Wegovy from Novo Nordisk surges, reaching $1 billion in just one quarter

SG Tylor

For Novo overall, there’s “a lot to be proud of” in 2023’s second quarter, the company’s head of North American ...